180 related articles for article (PubMed ID: 19590577)
1. Overgrowth of a mouse model of Simpson-Golabi-Behmel syndrome is partly mediated by Indian hedgehog.
Capurro MI; Li F; Filmus J
EMBO Rep; 2009 Aug; 10(8):901-7. PubMed ID: 19590577
[TBL] [Abstract][Full Text] [Related]
2. Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding.
Capurro MI; Xu P; Shi W; Li F; Jia A; Filmus J
Dev Cell; 2008 May; 14(5):700-11. PubMed ID: 18477453
[TBL] [Abstract][Full Text] [Related]
3. GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome.
Li M; Shuman C; Fei YL; Cutiongco E; Bender HA; Stevens C; Wilkins-Haug L; Day-Salvatore D; Yong SL; Geraghty MT; Squire J; Weksberg R
Am J Med Genet; 2001 Aug; 102(2):161-8. PubMed ID: 11477610
[TBL] [Abstract][Full Text] [Related]
4. Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome.
Cano-Gauci DF; Song HH; Yang H; McKerlie C; Choo B; Shi W; Pullano R; Piscione TD; Grisaru S; Soon S; Sedlackova L; Tanswell AK; Mak TW; Yeger H; Lockwood GA; Rosenblum ND; Filmus J
J Cell Biol; 1999 Jul; 146(1):255-64. PubMed ID: 10402475
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene.
Veugelers M; Cat BD; Muyldermans SY; Reekmans G; Delande N; Frints S; Legius E; Fryns JP; Schrander-Stumpel C; Weidle B; Magdalena N; David G
Hum Mol Genet; 2000 May; 9(9):1321-8. PubMed ID: 10814714
[TBL] [Abstract][Full Text] [Related]
6. The role of glypican-3 in the regulation of body size and cancer.
Filmus J; Capurro M
Cell Cycle; 2008 Sep; 7(18):2787-90. PubMed ID: 18787398
[TBL] [Abstract][Full Text] [Related]
7. Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling.
Chiao E; Fisher P; Crisponi L; Deiana M; Dragatsis I; Schlessinger D; Pilia G; Efstratiadis A
Dev Biol; 2002 Mar; 243(1):185-206. PubMed ID: 11846487
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of a novel intragenic deletion in GPC3 in three cousins with Simpson-Golabi-Behmel syndrome.
Schmidt J; Hollstein R; Kaiser FJ; Gillessen-Kaesbach G
Am J Med Genet A; 2017 May; 173(5):1400-1405. PubMed ID: 28371070
[TBL] [Abstract][Full Text] [Related]
9. OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner.
Gonzalez AD; Kaya M; Shi W; Song H; Testa JR; Penn LZ; Filmus J
J Cell Biol; 1998 Jun; 141(6):1407-14. PubMed ID: 9628896
[TBL] [Abstract][Full Text] [Related]
10. Loss of glypican-3 function causes growth factor-dependent defects in cardiac and coronary vascular development.
Ng A; Wong M; Viviano B; Erlich JM; Alba G; Pflederer C; Jay PY; Saunders S
Dev Biol; 2009 Nov; 335(1):208-15. PubMed ID: 19733558
[TBL] [Abstract][Full Text] [Related]
11. Familial Simpson-Golabi-Behmel syndrome: studies of X-chromosome inactivation and clinical phenotypes in two female individuals with GPC3 mutations.
Yano S; Baskin B; Bagheri A; Watanabe Y; Moseley K; Nishimura A; Matsumoto N; Ray PN
Clin Genet; 2011 Nov; 80(5):466-71. PubMed ID: 20950395
[TBL] [Abstract][Full Text] [Related]
12. Hedgehog pathway modulation by glypican 3-conjugated heparan sulfate.
Liu YC; Wierbowski BM; Salic A
J Cell Sci; 2022 Mar; 135(6):. PubMed ID: 35142364
[TBL] [Abstract][Full Text] [Related]
13. The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26.
Davoodi J; Kelly J; Gendron NH; MacKenzie AE
Proteomics; 2007 Jun; 7(13):2300-10. PubMed ID: 17549790
[TBL] [Abstract][Full Text] [Related]
14. Mutation update for the GPC3 gene involved in Simpson-Golabi-Behmel syndrome and review of the literature.
Vuillaume ML; Moizard MP; Rossignol S; Cottereau E; Vonwill S; Alessandri JL; Busa T; Colin E; Gérard M; Giuliano F; Lambert L; Lefevre M; Kotecha U; Nampoothiri S; Netchine I; Raynaud M; Brioude F; Toutain A
Hum Mutat; 2018 Jun; 39(6):790-805. PubMed ID: 29637653
[TBL] [Abstract][Full Text] [Related]
15. SIMPSON-GOLABI-BEHMEL syndrome type 1: How placental immunohistochemistry can rapidly Predict the diagnosis.
Fiandrino G; Arossa A; Ghirardello S; Kalantari S; Rossi C; Bonasoni MP; Cesari S; Rizzuti T; Giorgio E; Bassanese F; Scatigno AL; Meroni A; Melito C; Feltri M; Longo S; Figar TA; Andorno A; Gelli MC; Bertozzi M; Spinillo A; Riccipetitoni G; Valente EM; Paulli M; Sirchia F
Placenta; 2022 Aug; 126():119-124. PubMed ID: 35796063
[TBL] [Abstract][Full Text] [Related]
16. Somatic CTNNB1 mutation in hepatoblastoma from a patient with Simpson-Golabi-Behmel syndrome and germline GPC3 mutation.
Kosaki R; Takenouchi T; Takeda N; Kagami M; Nakabayashi K; Hata K; Kosaki K
Am J Med Genet A; 2014 Apr; 164A(4):993-7. PubMed ID: 24459012
[TBL] [Abstract][Full Text] [Related]
17. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome.
Pilia G; Hughes-Benzie RM; MacKenzie A; Baybayan P; Chen EY; Huber R; Neri G; Cao A; Forabosco A; Schlessinger D
Nat Genet; 1996 Mar; 12(3):241-7. PubMed ID: 8589713
[TBL] [Abstract][Full Text] [Related]
18. Glypican-3: a new target for cancer immunotherapy.
Ho M; Kim H
Eur J Cancer; 2011 Feb; 47(3):333-8. PubMed ID: 21112773
[TBL] [Abstract][Full Text] [Related]
19. LRP1 mediates Hedgehog-induced endocytosis of the GPC3-Hedgehog complex.
Capurro MI; Shi W; Filmus J
J Cell Sci; 2012 Jul; 125(Pt 14):3380-9. PubMed ID: 22467855
[TBL] [Abstract][Full Text] [Related]
20. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome.
Veugelers M; Vermeesch J; Watanabe K; Yamaguchi Y; Marynen P; David G
Genomics; 1998 Oct; 53(1):1-11. PubMed ID: 9787072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
